The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Semi-Solid Formulations Drug Delivery Market Research Report 2025

Global Semi-Solid Formulations Drug Delivery Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1708785

No of Pages : 94

Ask Your Query
Synopsis
The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
The global Semi-Solid Formulations Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Formulations Drug Delivery.
Report Scope
The Semi-Solid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Semi-Solid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Semi-Solid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Segment by Type
Creams
Ointments
Lotions
Gel
Pastes
Segment by Application
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Semi-Solid Formulations Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Creams
1.2.3 Ointments
1.2.4 Lotions
1.2.5 Gel
1.2.6 Pastes
1.3 Market by Application
1.3.1 Global Semi-Solid Formulations Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Home Care Settings
1.3.3 Hospitals & Clinics
1.3.4 Burn Centers
1.3.5 Other Facilities
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Semi-Solid Formulations Drug Delivery Market Perspective (2019-2030)
2.2 Semi-Solid Formulations Drug Delivery Growth Trends by Region
2.2.1 Global Semi-Solid Formulations Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Semi-Solid Formulations Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Semi-Solid Formulations Drug Delivery Market Dynamics
2.3.1 Semi-Solid Formulations Drug Delivery Industry Trends
2.3.2 Semi-Solid Formulations Drug Delivery Market Drivers
2.3.3 Semi-Solid Formulations Drug Delivery Market Challenges
2.3.4 Semi-Solid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue
3.1.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Semi-Solid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Semi-Solid Formulations Drug Delivery Revenue
3.4 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio
3.4.1 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Semi-Solid Formulations Drug Delivery Revenue in 2023
3.5 Semi-Solid Formulations Drug Delivery Key Players Head office and Area Served
3.6 Key Players Semi-Solid Formulations Drug Delivery Product Solution and Service
3.7 Date of Enter into Semi-Solid Formulations Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Semi-Solid Formulations Drug Delivery Breakdown Data by Type
4.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Semi-Solid Formulations Drug Delivery Breakdown Data by Application
5.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Semi-Solid Formulations Drug Delivery Market Size (2019-2030)
6.2 North America Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024)
6.4 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Semi-Solid Formulations Drug Delivery Market Size (2019-2030)
7.2 Europe Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Semi-Solid Formulations Drug Delivery Market Size (2019-2030)
9.2 Latin America Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glenmark Pharmaceuticals
11.1.1 Glenmark Pharmaceuticals Company Detail
11.1.2 Glenmark Pharmaceuticals Business Overview
11.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.1.4 Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.1.5 Glenmark Pharmaceuticals Recent Development
11.2 Galderma
11.2.1 Galderma Company Detail
11.2.2 Galderma Business Overview
11.2.3 Galderma Semi-Solid Formulations Drug Delivery Introduction
11.2.4 Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.2.5 Galderma Recent Development
11.3 Johnson & Johnson Private
11.3.1 Johnson & Johnson Private Company Detail
11.3.2 Johnson & Johnson Private Business Overview
11.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Introduction
11.3.4 Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.3.5 Johnson & Johnson Private Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Introduction
11.4.4 GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Bausch Health Companies
11.5.1 Bausch Health Companies Company Detail
11.5.2 Bausch Health Companies Business Overview
11.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Introduction
11.5.4 Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.5.5 Bausch Health Companies Recent Development
11.6 Hisamitsu Pharmaceuticals
11.6.1 Hisamitsu Pharmaceuticals Company Detail
11.6.2 Hisamitsu Pharmaceuticals Business Overview
11.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.6.4 Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.6.5 Hisamitsu Pharmaceuticals Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Semi-Solid Formulations Drug Delivery Introduction
11.7.4 Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.7.5 Cipla Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Semi-Solid Formulations Drug Delivery Introduction
11.8.4 Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Viatris
11.9.1 Viatris Company Detail
11.9.2 Viatris Business Overview
11.9.3 Viatris Semi-Solid Formulations Drug Delivery Introduction
11.9.4 Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.9.5 Viatris Recent Development
11.10 3M
11.10.1 3M Company Detail
11.10.2 3M Business Overview
11.10.3 3M Semi-Solid Formulations Drug Delivery Introduction
11.10.4 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.10.5 3M Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Detail
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Introduction
11.11.4 Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.11.5 Merck & Co Recent Development
11.12 Crescita Therpeautics
11.12.1 Crescita Therpeautics Company Detail
11.12.2 Crescita Therpeautics Business Overview
11.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Introduction
11.12.4 Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.12.5 Crescita Therpeautics Recent Development
11.13 Novartis International
11.13.1 Novartis International Company Detail
11.13.2 Novartis International Business Overview
11.13.3 Novartis International Semi-Solid Formulations Drug Delivery Introduction
11.13.4 Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.13.5 Novartis International Recent Development
11.14 Boehringer Ingelheim
11.14.1 Boehringer Ingelheim Company Detail
11.14.2 Boehringer Ingelheim Business Overview
11.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Introduction
11.14.4 Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.14.5 Boehringer Ingelheim Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Detail
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Semi-Solid Formulations Drug Delivery Introduction
11.15.4 Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.15.5 Pfizer Recent Development
11.16 Teva Pharmaceuticals
11.16.1 Teva Pharmaceuticals Company Detail
11.16.2 Teva Pharmaceuticals Business Overview
11.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.16.4 Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.16.5 Teva Pharmaceuticals Recent Development
11.17 Bristol Myers Squibb
11.17.1 Bristol Myers Squibb Company Detail
11.17.2 Bristol Myers Squibb Business Overview
11.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Introduction
11.17.4 Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.17.5 Bristol Myers Squibb Recent Development
11.18 Lead Chemical
11.18.1 Lead Chemical Company Detail
11.18.2 Lead Chemical Business Overview
11.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Introduction
11.18.4 Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.18.5 Lead Chemical Recent Development
11.19 Purdue Pharma
11.19.1 Purdue Pharma Company Detail
11.19.2 Purdue Pharma Business Overview
11.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Introduction
11.19.4 Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024)
11.19.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Creams
Table 3. Key Players of Ointments
Table 4. Key Players of Lotions
Table 5. Key Players of Gel
Table 6. Key Players of Pastes
Table 7. Global Semi-Solid Formulations Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Semi-Solid Formulations Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Semi-Solid Formulations Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Semi-Solid Formulations Drug Delivery Market Share by Region (2019-2024)
Table 11. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Semi-Solid Formulations Drug Delivery Market Share by Region (2025-2030)
Table 13. Semi-Solid Formulations Drug Delivery Market Trends
Table 14. Semi-Solid Formulations Drug Delivery Market Drivers
Table 15. Semi-Solid Formulations Drug Delivery Market Challenges
Table 16. Semi-Solid Formulations Drug Delivery Market Restraints
Table 17. Global Semi-Solid Formulations Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Semi-Solid Formulations Drug Delivery Market Share by Players (2019-2024)
Table 19. Global Top Semi-Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Formulations Drug Delivery as of 2023)
Table 20. Ranking of Global Top Semi-Solid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Semi-Solid Formulations Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Semi-Solid Formulations Drug Delivery Product Solution and Service
Table 24. Date of Enter into Semi-Solid Formulations Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Semi-Solid Formulations Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Type (2019-2024)
Table 28. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Type (2025-2030)
Table 30. Global Semi-Solid Formulations Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Application (2019-2024)
Table 32. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Application (2025-2030)
Table 34. North America Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 49. Glenmark Pharmaceuticals Company Detail
Table 50. Glenmark Pharmaceuticals Business Overview
Table 51. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
Table 52. Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 53. Glenmark Pharmaceuticals Recent Development
Table 54. Galderma Company Detail
Table 55. Galderma Business Overview
Table 56. Galderma Semi-Solid Formulations Drug Delivery Product
Table 57. Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 58. Galderma Recent Development
Table 59. Johnson & Johnson Private Company Detail
Table 60. Johnson & Johnson Private Business Overview
Table 61. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Product
Table 62. Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 63. Johnson & Johnson Private Recent Development
Table 64. GlaxoSmithKline Company Detail
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Product
Table 67. GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Bausch Health Companies Company Detail
Table 70. Bausch Health Companies Business Overview
Table 71. Bausch Health Companies Semi-Solid Formulations Drug Delivery Product
Table 72. Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 73. Bausch Health Companies Recent Development
Table 74. Hisamitsu Pharmaceuticals Company Detail
Table 75. Hisamitsu Pharmaceuticals Business Overview
Table 76. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
Table 77. Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 78. Hisamitsu Pharmaceuticals Recent Development
Table 79. Cipla Company Detail
Table 80. Cipla Business Overview
Table 81. Cipla Semi-Solid Formulations Drug Delivery Product
Table 82. Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 83. Cipla Recent Development
Table 84. Bayer Company Detail
Table 85. Bayer Business Overview
Table 86. Bayer Semi-Solid Formulations Drug Delivery Product
Table 87. Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 88. Bayer Recent Development
Table 89. Viatris Company Detail
Table 90. Viatris Business Overview
Table 91. Viatris Semi-Solid Formulations Drug Delivery Product
Table 92. Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 93. Viatris Recent Development
Table 94. 3M Company Detail
Table 95. 3M Business Overview
Table 96. 3M Semi-Solid Formulations Drug Delivery Product
Table 97. 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 98. 3M Recent Development
Table 99. Merck & Co Company Detail
Table 100. Merck & Co Business Overview
Table 101. Merck & Co Semi-Solid Formulations Drug Delivery Product
Table 102. Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 103. Merck & Co Recent Development
Table 104. Crescita Therpeautics Company Detail
Table 105. Crescita Therpeautics Business Overview
Table 106. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Product
Table 107. Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 108. Crescita Therpeautics Recent Development
Table 109. Novartis International Company Detail
Table 110. Novartis International Business Overview
Table 111. Novartis International Semi-Solid Formulations Drug Delivery Product
Table 112. Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 113. Novartis International Recent Development
Table 114. Boehringer Ingelheim Company Detail
Table 115. Boehringer Ingelheim Business Overview
Table 116. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Product
Table 117. Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 118. Boehringer Ingelheim Recent Development
Table 119. Pfizer Company Detail
Table 120. Pfizer Business Overview
Table 121. Pfizer Semi-Solid Formulations Drug Delivery Product
Table 122. Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 123. Pfizer Recent Development
Table 124. Teva Pharmaceuticals Company Detail
Table 125. Teva Pharmaceuticals Business Overview
Table 126. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
Table 127. Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 128. Teva Pharmaceuticals Recent Development
Table 129. Bristol Myers Squibb Company Detail
Table 130. Bristol Myers Squibb Business Overview
Table 131. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Product
Table 132. Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 133. Bristol Myers Squibb Recent Development
Table 134. Lead Chemical Company Detail
Table 135. Lead Chemical Business Overview
Table 136. Lead Chemical Semi-Solid Formulations Drug Delivery Product
Table 137. Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 138. Lead Chemical Recent Development
Table 139. Purdue Pharma Company Detail
Table 140. Purdue Pharma Business Overview
Table 141. Purdue Pharma Semi-Solid Formulations Drug Delivery Product
Table 142. Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 143. Purdue Pharma Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Semi-Solid Formulations Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Semi-Solid Formulations Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Creams Features
Figure 4. Ointments Features
Figure 5. Lotions Features
Figure 6. Gel Features
Figure 7. Pastes Features
Figure 8. Global Semi-Solid Formulations Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Semi-Solid Formulations Drug Delivery Market Share by Application: 2023 VS 2030
Figure 10. Home Care Settings Case Studies
Figure 11. Hospitals & Clinics Case Studies
Figure 12. Burn Centers Case Studies
Figure 13. Other Facilities Case Studies
Figure 14. Semi-Solid Formulations Drug Delivery Report Years Considered
Figure 15. Global Semi-Solid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Semi-Solid Formulations Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Semi-Solid Formulations Drug Delivery Market Share by Region: 2023 VS 2030
Figure 18. Global Semi-Solid Formulations Drug Delivery Market Share by Players in 2023
Figure 19. Global Top Semi-Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Formulations Drug Delivery as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Semi-Solid Formulations Drug Delivery Revenue in 2023
Figure 21. North America Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Semi-Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 23. United States Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Semi-Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 27. Germany Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Share by Region (2019-2030)
Figure 35. China Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Semi-Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 43. Mexico Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 47. Turkey Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Glenmark Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 50. Galderma Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 51. Johnson & Johnson Private Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 53. Bausch Health Companies Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 54. Hisamitsu Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 55. Cipla Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 56. Bayer Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 57. Viatris Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 58. 3M Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 59. Merck & Co Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 60. Crescita Therpeautics Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 61. Novartis International Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 63. Pfizer Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 64. Teva Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 65. Bristol Myers Squibb Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 66. Lead Chemical Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 67. Purdue Pharma Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock